Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced on November 25 that it has entered into a definitive agreement to acquire Newton, Massachusetts-based Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine – a chemotherapy drug – both of which are approved by the U.S. Food and Drug Administration. The Intera 3000 pump is used to administer hepatic artery infusion therapy to treat tumors in the liver primarily caused by metastatic colorectal cancer. Boston Scientific develops and manufactures minimally invasive medical devices used in interventional cardiology, cardiac rhythm management, peripheral... Read More »
Earnings Week in Review: Navigating Challenges and Growth in Q3 2024 Healthcare
We’re taking a look at some of the major companies reporting earnings in the week of October 28 – November 1, across a variety of sectors. Managed Care providers Humana and Cigna reported significant growth, driven by their health insurance offerings. The eHealth space saw Teladoc Health and American Well Corp. navigating competitive pressures and market shifts, highlighting the dynamic nature of digital health. Meanwhile, Stryker Corp.’s strong earnings performance in the Medical Devices segment contrasted with Avanos Medical’s struggle with cost pressures. These earnings reports offer a comprehensive view of the healthcare industry’s current performance and future... Read More »
Archimed Strengthens Presence in Occupational Health Medical Device Market With Acquisition
Global private equity healthcare specialist Archimed announced on October 16 that it has acquired FIM Medical. The company is being acquired by ArchiMed’s latest fund, MED Rise, which closed on €400 million (approximately USD $436 million) in April 2024. FIM Medical is a prominent company in the French occupational health medical device market. The company is a designer, manufacturer and supplier of medical screening devices. It provides vision, hearing and respiratory care products, using proprietary technology in both its medical devices and software. ArchiMed is an independent investment firm focused exclusively on healthcare industries. It has directly managed and invested in... Read More »
Hologic Acquires Gynesonics for $350 Million
On October 14, Marlborough, Massachusetts-based Hologic, Inc. announced that it entered into an agreement to acquire Gynesonics, Inc. for $350 million. Founded in 2005 and based in Redwood City, California, Gynesonics develops and sells the Sonata System. The Sonata System is a technology intended for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. Hologic, Inc. develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. According to its most recent annual report,... Read More »
Caldera Medical Expands Minimally Invasive Hysteroscopy Portfolio With UVision360 Acquisition
On October 8, Caldera Medical announced the acquisition of UVision 360, Inc., the developer of the LUMINELLE® hysteroscopy and cystoscopy systems. Financial terms of the deal were not disclosed. UVision 360 designs and develops innovative, minimally invasive hysteroscopy and cystoscopy systems that enhance precision and patient outcomes in gynecologic procedures. The company’s LUMINELLE® system offers visualization and a simplified workflow, helping physicians in clinical and surgical settings. Headquartered in Westlake, California, Caldera Medical is a privately held women’s health medical device company focused on minimally invasive applications. The acquisition of UVision... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
